Clinical Trial Update: Maintenance Gemcitabine in the Chinese Advanced Lung Cancer [Phase 4]

View source ↗

Summary

Phase 4 maintenance trial of gemcitabine for non-small cell lung cancer in Chinese patients, with the trial status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemzar) (gemcitabine)

Snippet

Sponsor: Tongji University | Conditions: Non Small Cell Lung Cancer | Phase 4 | Status: UNKNOWN